Q9995 HCPCS 2026 Code: Injection, emicizumab-kxwh, 0.5 mg

Codes in This Family (40)

Official HCPCS Level II classifications in the same code family as Q9995, with their registry titles.

• Q9950 — Injection, sulfur hexafluoride lipid microspheres, per ml
• Q9951 — Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
• Q9953 — Injection, iron-based magnetic resonance contrast agent, per ml
• Q9954 — Oral magnetic resonance contrast agent, per 100 ml
• Q9955 — Injection, perflexane lipid microspheres, per ml
• Q9956 — Injection, octafluoropropane microspheres, per ml
• Q9957 — Injection, perflutren lipid microspheres, per ml
• Q9958 — High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
• Q9959 — High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
• Q9960 — High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
• Q9961 — High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
• Q9962 — High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
• Q9963 — High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
• Q9964 — High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
• Q9965 — Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
• Q9966 — Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
• Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
• Q9968 — Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
• Q9969 — Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
• Q9970 — Injection, ferric carboxymaltose, 1mg
• Q9972 — Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
• Q9973 — Injection, epoetin beta, 1 microgram, (non-esrd use)
• Q9974 — Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
• Q9975 — Injection, factor viii fc fusion protein (recombinant), per iu
• Q9976 — Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
• Q9977 — Compounded drug, not otherwise classified
• Q9978 — Netupitant 300 mg and palonosetron 0.5 mg
• Q9979 — Injection, alemtuzumab, 1 mg
• Q9980 — Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
• Q9981 — Rolapitant, oral, 1 mg
• Q9982 — Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
• Q9983 — Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
• Q9984 — Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
• Q9985 — Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
• Q9986 — Injection, hydroxyprogesterone caproate, (makena), 10 mg
• Q9987 — Pathogen(s) test for platelets
• Q9988 — Platelets, pheresis, pathogen-reduced, each unit
• Q9989 — Ustekinumab, for intravenous injection, 1 mg
• Q9991 — Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
• Q9992 — Injection, buprenorphine extended-release (sublocade), greater than 100 mg

Related Codes & Numerical Sequence (Crawl Map)

Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures: